The bill, known as the 340B Contract Pharmacy Protection Act, establishes protections for 340B entities, which are healthcare providers that can purchase drugs at reduced prices under federal law. It prohibits manufacturers, their agents, or third-party logistics providers from denying or restricting the acquisition or delivery of 340B drugs to authorized locations, unless such actions are mandated by federal law. Additionally, it prevents these entities from requiring 340B entities to submit various types of data as a condition for drug acquisition or delivery, again unless required by federal law.

The bill also empowers the Attorney General or county attorneys to take legal action against violations of the Act, ensuring enforcement of its provisions. Importantly, it clarifies that the Act will not conflict with federal law or other compatible state laws. The bill includes a severability clause, ensuring that if any part is found invalid, the remaining sections will still be effective. Due to the urgency of the matter, the Act is set to take effect immediately upon passage and approval.